Imunon, Inc. (IMNN)
Imunon Market Cap : 6.196M for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.707B |
| Alnylam Pharmaceuticals, Inc. | 42.72B |
| Savara, Inc. | 1.158B |
| BioMarin Pharmaceutical, Inc. | 10.49B |
| Corcept Therapeutics, Inc. | 4.458B |
Market Cap Related Metrics
| Price to Book Value | 0.8774 |
| Price | 2.92 |
| Earnings Yield | -157.7% |